(Q37122421)

18 August 2017

1 reference

title

Contributions of non-human primates to neuroscience research (English)

1 reference

18 August 2017

1 reference

2

Marina E Emborg

1 reference

18 August 2017

John P Capitanio

1

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

371

1 reference

18 August 2017

issue

9618

1 reference

18 August 2017

page(s)

1126-1135

1 reference

Use of primates in research: a global overview

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Memory impairment in aged primates is associated with focal death of cortical neurons and atrophy of subcortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Calorie restriction mimetics: an emerging research field

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

The cortical control of movement revisited.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Models of focal cerebral ischemia in the nonhuman primate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Non-human primate models of neonatal brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Effects of ovarian hormones on cognitive function in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Nonhuman primate models of intrauterine cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Alzheimer Disease in the US Population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

1 reference

7 January 2021

Genes involved in Alzheimer's disease, a survey of possible candidates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Memory decline: the boundary between aging and age-related disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Alzheimer's disease and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

NICE recommends drugs for moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Molecular insights into human brain evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

A memory system in the monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Aged Non-Human Primates: An Animal Model of Age-Associated Neurodegenerative Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Neurobiological bases of age-related cognitive decline in the rhesus monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Executive system dysfunction occurs as early as middle-age in the rhesus monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Reproductive senescence predicts cognitive decline in aged female monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Synaptic remodeling during aging and in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Neuritic (senile) plaques and filamentous changes in aged rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Senile plaques in aged squirrel monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

My own experience in early research on Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Lack of correlation between plaque burden and cognition in the aged monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

A primate model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Basal forebrain lesions in monkeys disrupt attention but not learning and memory

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Response of the monkey cholinergic septohippocampal system to fornix transection: a histochemical and cytochemical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Neuroprotection and neurodegenerative diseases: from biology to clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: lessons from mice, monkeys, and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Nerve growth factor expressed in the medial septum following in vivo gene delivery using a recombinant adeno-associated viral vector protects cholinergic neurons from fimbria-fornix lesion-induced degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Neuroreplacement therapy and stem cell biology under disease conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Stem cells for Parkinson disease and ALS: replacement or protection?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

HIV dementia: an evolving disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

The neuropathogenesis of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Neurological complications of HIV infection and AIDS: current and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

AIDS as a zoonosis: scientific and public health implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Social separation, housing relocation, and survival in simian AIDS: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

From mice to macaques--animal models of HIV nervous system disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Macaque animal model for HIV-induced neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Relationship between viral load in blood, cerebrospinal fluid, brain tissue and isolated microglia with neurological disease in macaques infected with different strains of SIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Role of microglial cells in selective replication of simian immunodeficiency virus genotypes in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Development and characterization of positively selected brain-adapted SIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Enhanced expression of proinflammatory cytokines in the central nervous system is associated with neuroinvasion by simian immunodeficiency virus and the development of encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Acute SIV infection of the brain leads to upregulation of IL6 and interferon-regulated genes: expression patterns throughout disease progression and impact on neuroAIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Early brain injury in the SIV-macaque model of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

In vivo 1H MRS of brain injury and repair during acute SIV infection in the macaque model of neuroAIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Impaired performance on a rhesus monkey neuropsychological testing battery following simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Monoamine metabolite levels in CSF of SIV-infected rhesus monkeys (Macaca mulatta).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Early impairment in dopaminergic neurotransmission in brains of SIV-infected rhesus monkeys due to microglia activation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Modulation of simian immunodeficiency virus neuropathology by dopaminergic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Neuroprotective and anti-human immunodeficiency virus activity of minocycline

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Parkinson's disease risk factors: genetic, environmental, or both?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Protein aggregation and neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Parkinson's disease management strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Pathophysiology of levodopa-induced dyskinesia: potential for new therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Motor slowing and parkinsonian signs in aging rhesus monkeys mirror human aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

The role of alpha-synuclein in Parkinson's disease: insights from animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Evaluation of animal models of Parkinson's disease for neuroprotective strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

MPTP as a mitochondrial neurotoxic model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Localization of monoamine oxidase A and B mRNA in the rat brain by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Primate models of movement disorders of basal ganglia origin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

The MPTP-treated primate as a model of motor complications in PD: primate model of motor complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Sympathetic innervation in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Nocturnal sleep structure and temperature slope in MPTP treated monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Circadian determinations of cortisol, prolactin and melatonin in chronic methyl-phenyl-tetrahydropyridine-treated monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Effects of transient focal inactivation of the basal ganglia in parkinsonian primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

The contribution of the MPTP-treated primate model to the development of new treatment strategies for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Cellular replacement therapy for Parkinson's disease--where we are today?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Pluripotent cell lines derived from common marmoset (Callithrix jacchus) blastocysts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: a return to control measures.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (cyno-1) after transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Subthalamic GAD gene therapy in a Parkinson's disease rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Pharmacological activities of glial cell line-derived neurotrophic factor (GDNF): preclinical development and application to the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Encapsulated GDNF-producing C2C12 cells for Parkinson's disease: a pre-clinical study in chronic MPTP-treated baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Crossroads in GDNF therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Point source concentration of GDNF may explain failure of phase II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

The relationship between modifiable health risks and health care expenditures. An analysis of the multi-employer HERO health risk and cost database

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Personality characteristics and basal cortisol concentrations in adult male rhesus macaques (Macaca mulatta).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Personality influences tetanus‐specific antibody response in adult male rhesus macaques after removal from natal group and housing relocation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Cerebrospinal fluid corticotropin-releasing hormone levels are elevated in monkeys with patterns of brain activity associated with fearful temperament.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Fetal programming of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Fetal programming of hypothalamo-pituitary-adrenal function: prenatal stress and glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Maternal endocrine activation during pregnancy alters neurobehavioral state in primate infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Long-term effects of prenatal stress on HPA axis activity in juvenile rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Prenatal stress diminishes neurogenesis in the dentate gyrus of juvenile rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Prenatal endocrine activation alters postnatal cellular immunity in infant monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Prenatal stress diminishes the cytokine response of leukocytes to endotoxin stimulation in juvenile rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Prenatal stress alters bacterial colonization of the gut in infant monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Maternal absence and stability of individual differences in CSF 5-HIAA concentrations in rhesus monkey infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Rearing experiences and stress-induced plasma cortisol as early risk factors for excessive alcohol consumption in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Rearing effects on cerebrospinal fluid oxytocin concentration and social buffering in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Serotonin transporter gene polymorphism, differential early rearing, and behavior in rhesus monkey neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Early experience and serotonin transporter gene variation interact to influence primate CNS function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Interaction between serotonin transporter gene variation and rearing condition in alcohol preference and consumption in female primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

Rearing condition and rh5-HTTLPR interact to influence limbic-hypothalamic-pituitary-adrenal axis response to stress in infant macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

The National Institutes of Health Blueprint for Neuroscience Research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960489-4

7 January 2021

10.1016/S0140-6736(08)60489-4

Identifiers

DOI

1 reference

18 August 2017

1 reference